| AA (N = 53) | nAA (N = 33) |
---|---|---|
Age in years, median (range) | 13.8 (12–18) | 13.5 (12–18) |
Sex – Feale, n(%) | 26 (50%) | 14 (42%) |
Race/Ethnicity to which subject self-identifies | 53 African-American | 25 Caucasian 2 Asian 5 Hispanic/Latino 1 Native American |
BMI %tile for age/sex, median (range) | 72 (3–99) | 72 (1–99) |
% predicted FEV1, median (range) | 93 (50–138) | 92 (54–114) |
% predicted FEV1, n (%) | ||
  < 60% | 1 (2) | 1 (3) |
 60–79% | 8 (15) | 2 (6) |
 80–100% | 26 (49) | 23 (70) |
  > 100% | 18 (34) | 7 (21) |
NAEPP Treatment Step, n (%) | Step 2–6 (11) | Step 2–7 (21) |
Step 3–11 (21) | Step 3–10 (30) | |
Step 4–8 (15) | Step 4–7 (21) | |
Step 5–26 (49) | Step 5–7 (21) | |
Step 6–0 (0) | Step 6–1 (3) | |
Unknown – 2 (4) | Unknown – 1 (3) | |
Asthma Control, n (%) | Well controlled – 21 (40) | Well controlled – 19 (58) |
Not well controlled – 32 (60) | Not well controlled - 14 (42) | |
History of atopic disease, N (%) | 49 (92) | 30 (91) |